Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Moderna (MRNA) : "This is a speculative one, but these guys are winners. Good call with this one."
Exelixis (EXEL) : "We like Exelixis, but it's speculative. We're on board."
Maxar Technology (MAXR) : "No, this one's way too speculative. Don't buy it."
International Paper (IP) : "They're a play on worldwide growth and there isn't enough, so we're going to stay away from IP.
Cramer and the AAP team are initiating a position in Lam Research (LRCX) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.
On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.